Second Malignancies on BRAF Inhibitor Therapy

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户：hotjune

【摘要】

：

Vemurafenib,a specific inhibitor of mutated BRAF kinase,may activate wild-type BRAF and therefore induce secondary malignancies in patients treated for melanoma.

【作者】

：

Aleksei Novik

【机构】

：

N.N.Petrov Research Institute of Oncology Russia

【出处】

：

2016第九届世界癌症大会

【发表日期】

：

2016年7期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Vemurafenib,a specific inhibitor of mutated BRAF kinase,may activate wild-type BRAF and therefore induce secondary malignancies in patients treated for melanoma.

其他文献

Cancer and Nanotechnology

Therapies of liver tumors display diverse treatment alternatives.The administration of cytostatics coupled with and without iron oxides (Fe3O4) has been presented in an experimental series with 36 ani

会议

Pyrimidine Derivatives for the Treatment of Gastrointestinal Cancer:History, Current Status and Poss

In the 1950s,5-fluorouracil (5-FU) was first rationally synthesized by Dr.Charles Heidelberger and,shortly thereafter,became the most extensively used chemotherapeutic agent.

会议

Appraising Thyroid Cystic Fluids

Fine-needle aspiration (FNA) is first-hand tool to distinguish thyroid nodule cases that need surgery from those need not.The aspirations sometimes obtain fluid varying from little to tens of millilit

会议

Three Generations of EGFR Inhibitors, What Will Be the Next?

Three generations of synthetic small molecule inhibitors against human epidermal growth factor receptors (EGFRs) as far have been developed,many of them have been approved for cancer treatment.

会议

Core Needle Biopsy of Soft Tissue Tumors, CEUS vs.US Guided: A Pilot Study

Purpose of this study was to evaluate theusefulness of contrast-enhanced ultrasonography (CEUS) in the bioptic sampling of soft tissue tumors (STT) comparedwith unenhanced ultrasonography alone.

会议

A Novel Epigenetic Mechanism Associated with Glucocorticoid Resistance in Pediatric Acute Lymphoblas

Glucocorticoids are critical components of combination chemotherapy regimens in pediatric acute lymphoblastic leukemia (ALL).However,the emergence of resistance remains a significant barrier to cure,a

会议

Personalized Cell Technologies for Cancer Treatment: Laboratory and Manufacturing Issues

Personalized cell therapies are the most radical of several new approaches that recruit the immune system to attack cancers.Medicine is entering a new phase in which cells will become "living drugs".

会议

Pure Erythroleukemia with Deletion of Chromosome 20, Mainly Presenting as Late Erythroblasts.A Uniqu

Acute Erythroleukemia is characterizes by a predominant immature erythroid population and accounts for approximately 2-5 % of all cases of acute leukemia.

会议

Genome-wide SNP Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/Lymphoma

Chromosomal abnormalities are important for the risk stratification of acute lymphoblastic leukemia/lymphoma (ALL).However,approximately 30% of pediatric and 50% of adult patients lack abnormalities w

会议

Epigenetics Effects of Stress on Genomics, Proteomics, Metabolomics of Addiction and Cancer

Metabolic & genetic changes instigated by Stress are involved in the pathogenesis of Addiction & Cancer through a Genomics,Transcriptomics,Proteonomic & Metabolomics cascade.

会议

Second Malignancies on BRAF Inhibitor Therapy

其他学术论文